There is a laundry list of companies that have market capitalizations of more than $100 billion that look like buys ...

We recently published a list of Was Jim Cramer Right About These 23 Stocks? In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim ...

Volatile times in markets require extra precision, says Goldman Sachs chief US equity strategist David Kostin. In a new note on Friday, Kostin offered three recommendations for investors dealing with ...

Taking a look back at 12 memorable clashes between modern day masters Melbourne and Penrith ahead of their grand final ...

Hard-hit “Magnificent Seven” stocks can bounce into the next earnings season, says Morgan Stanley’s Mike Wilson. There are a ...

Earnings pessimism for The Magnificent Seven stocks look like it's approaching a bottom, and the group's revival could boost ...

Meta on Tuesday became the last of the Magnificent Seven stocks to fall into negative territory for the year. The seven tech ...

Some of the so-called Magnificent Seven stocks were up sharply Monday, leading Wall Street's rebound after news reports indicated that the Trump administration's plans for reciprocal tariffs due on ...

Nvidia has been the top-performing stock among the "Magnificent Seven" over the last few years, but I see another megacap AI stock as the better long-term buy.

US large-cap growth stocks, particularly the Russell 1000 Growth Index, are in correction territory, with the Lag 7 stocks ...

Eli Lilly stock has generated fantastic returns for investors over the past five years. The company possesses many lucrative growth opportunities to ensure it remains an excellent buy in the years ...